Pilbrant A, Schannong M, Vessman J
Eur J Clin Pharmacol. 1981;20(1):65-72. doi: 10.1007/BF00554669.
Tranexamic acid 1 g was given intravenously to three healthy volunteers. Plasma concentrations decayed in three monoexponential phases. Most elimination took place during the first eight hours, giving an apparent elimination half-life of approximately two hours. Plasma clearance ranged between 110-116 ml/min. The urinary recovery of tranexamic acid exceeded 95% of the dose. Ten healthy volunteers were given tranexamic acid 2 g orally on an empty stomach, and together with a meal. Food had no influence on the absorption of tranexamic acid, as judged by comparison of the peak plasma concentration, the time required to reach the peak, the AUC from zero to six hours, and the urinary excretion data. The oral bioavailability of tranexamic acid, calculated from 24 h urinary excretion after oral and intravenous administration, was 34% of the dose.
给三名健康志愿者静脉注射1克氨甲环酸。血浆浓度呈三个单指数相衰减。大部分消除发生在前8小时,表观消除半衰期约为2小时。血浆清除率在110 - 116毫升/分钟之间。氨甲环酸的尿回收率超过给药剂量的95%。十名健康志愿者空腹及与食物一起口服2克氨甲环酸。通过比较血浆峰浓度、达到峰浓度所需时间、零至6小时的曲线下面积以及尿排泄数据判断,食物对氨甲环酸的吸收无影响。根据口服和静脉给药后24小时尿排泄计算,氨甲环酸的口服生物利用度为给药剂量的34%。